Merck gives potential drug back to Durham's Chimerix
May 16, 2014 at 16:58 PM EDT
Drug giant Merck & Co. decided to abandon what it once hoped could turn into a treatment for HIV and gave the product back to Chimerix, a smaller drug developer in Durham...
